Thursday, December 19, 2024
HomeTagsKyverna

Kyverna

First-in-Disease Use of Kyverna Therapeutics’ KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med

Kyverna Therapeutics, Inc, a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announces today the publication in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics